Teva Pharma (TEVA) Tops Q4 EPS by 5c, Revenues Beat; Offers FY21 EPS/Revenue Guidance
Go back to Teva Pharma (TEVA) Tops Q4 EPS by 5c, Revenues Beat; Offers FY21 EPS/Revenue Guidance| TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) | Delayed: 40.06 +1.08 (2.77%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $38.98 | 52 Week High | $66.55 | |||
| Open | $39.09 | 52 Week Low | $37.82 | |||
| Day High | $40.79 | P/E | N/A | |||
| Day Low | $38.36 | EPS | $0.00 | |||
| Volume | 5,941,719 | |||||
